PHA-665752

TargetMol
Product Code: TAR-T6128
Supplier: TargetMol
CodeSizePrice
TAR-T6128-5mg5mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6128-1mL1 mL * 10 mM (in DMSO)£139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6128-10mg10mg£145.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6128-25mg25mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6128-50mg50mg£306.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6128-100mg100mg£462.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
PHA-665752 is an effective, specific and ATP-competitive c-Met inhibitor (IC50: 9 nM), >50-fold selectivity for c-Met than STKs or RTKs.
CAS:
477575-56-7
Formula:
C32H34Cl2N4O4S
Molecular Weight:
641.61
Pathway:
Angiogenesis; Cytoskeletal Signaling; Autophagy; Tyrosine Kinase/Adaptors; Apoptosis
Purity:
0.9935
SMILES:
Cc1[nH]c(C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1
Target:
Apoptosis; VEGFR; FGFR; c-Met/HGFR; Bcr-Abl; Autophagy

References

Yuan S, Gong Y, Chen R, et al. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Biomedicine & Pharmacotherapy. 2020, 132: 110867. Christensen JG, et al. Cancer Res, 2003, 63(21), 7345-7355. Ma PC, et al. Clin Cancer Res, 2005, 11(6), 2312-2319. Puri N, et al. Cancer Res, 2007, 67(8), 3529-3534.